Alimera Sciences Inc.

NASDAQ: ALIM · Real-Time Price · USD
5.54
-0.01 (-0.18%)
At close: Sep 13, 2024, 10:00 PM

Alimera Sciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-20.13M -18.11M -4.37M
Depreciation & Amortization
8.75M 2.71M 2.58M
Stock-Based Compensation
1.44M 910K 997K
Other Working Capital
3.49M 1.07M -609K
Other Non-Cash Items
11.46M 1.71M -1.69M
Deferred Income Tax
29K 116K 610K
Change in Working Capital
-15.8M 2.69M -1.35M
Operating Cash Flow
-14.26M -9.97M -3.22M
Capital Expenditures
-75.53M -255K -621K
Cash Acquisitions
n/a n/a n/a
Purchase of Investments
n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a
Other Investing Acitivies
-75.27M n/a n/a
Investing Cash Flow
-75.53M -255K -621K
Debt Repayment
22.02M -289K -221K
Common Stock Repurchased
-314K n/a n/a
Dividend Paid
-1.26M n/a n/a
Other Financial Acitivies
-4.03M -98K -40K
Financial Cash Flow
96.5M -302K 9.82M
Net Cash Flow
6.79M -11.24M 5.3M
Free Cash Flow
-89.79M -10.23M -3.85M